Your browser doesn't support javascript.
loading
Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries, L-K; Dal Ferro, G A; van Os, J; Delespaul, P; Kenis, G; Lin, B D; Luykx, J J; Richards, A L; Akdede, B; Binbay, T; Altinyazar, V; Yalinçetin, B; Gümüs-Akay, G; Cihan, B; Soygür, H; Ulas, H; Sahin Cankurtaran, E; Ulusoy Kaymak, S; Mihaljevic, M M; Andric Petrovic, S; Mirjanic, T; Bernardo, M; Mezquida, G; Amoretti, S; Bobes, J; Saiz, P A; García-Portilla, M Paz; Sanjuan, J; Aguilar, E J; Santos, J L; Jiménez-López, E; Arrojo, M; Carracedo, A; López, G; González-Peñas, J; Parellada, M; Maric, N P; Atbasoglu, C; Ucok, A; Alptekin, K; Can Saka, M; Arango, C; O'Donovan, M; Tosato, S; Rutten, B P F; Guloksuz, S.
Afiliação
  • Pries LK; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Dal Ferro GA; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
  • van Os J; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Delespaul P; Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Kenis G; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Lin BD; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Luykx JJ; FACT, Mondriaan Mental Health, Maastricht, Netherlands.
  • Richards AL; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Akdede B; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Binbay T; Department of Psychiatry, UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Altinyazar V; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Yalinçetin B; GGNet Mental Health, Apeldoorn, The Netherlands.
  • Gümüs-Akay G; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
  • Cihan B; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Soygür H; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Ulas H; Department of Psychiatry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.
  • Sahin Cankurtaran E; Department of Neuroscience, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey.
  • Ulusoy Kaymak S; Department of Physiology, School of Medicine, Ankara University, Ankara, Turkey.
  • Mihaljevic MM; Brain Research Center, Ankara University, Ankara, Turkey.
  • Andric Petrovic S; Department of Psychology, Middle East Technical University, Ankara, Turkey.
  • Mirjanic T; Turkish Federation of Schizophrenia Associations, Ankara, Turkey.
  • Bernardo M; Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Mezquida G; Güven Çayyolu Healthcare Campus, Ankara, Turkey.
  • Amoretti S; Atatürk Research and Training Hospital Psychiatry Clinic, Ankara, Turkey.
  • Bobes J; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Saiz PA; Clinic for Psychiatry Clinical Centre of Serbia, Belgrade, Serbia.
  • García-Portilla MP; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Sanjuan J; Clinic for Psychiatry Clinical Centre of Serbia, Belgrade, Serbia.
  • Aguilar EJ; Special Hospital for Psychiatric Disorders Kovin, Kovin, Serbia.
  • Santos JL; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Jiménez-López E; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • Arrojo M; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Carracedo A; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • López G; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • González-Peñas J; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Parellada M; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Maric NP; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • Atbasoglu C; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Ucok A; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • Alptekin K; Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
  • Can Saka M; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Arango C; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
  • O'Donovan M; Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
  • Tosato S; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Rutten BPF; Mental Health Services of Principado de Asturias, Oviedo, Spain.
  • Guloksuz S; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Epidemiol Psychiatr Sci ; 29: e182, 2020 Nov 17.
Article em En | MEDLINE | ID: mdl-33200977
ABSTRACT

AIMS:

Psychosis spectrum disorder has a complex pathoetiology characterised by interacting environmental and genetic vulnerabilities. The present study aims to investigate the role of gene-environment interaction using aggregate scores of genetic (polygenic risk score for schizophrenia (PRS-SCZ)) and environment liability for schizophrenia (exposome score for schizophrenia (ES-SCZ)) across the psychosis continuum.

METHODS:

The sample consisted of 1699 patients, 1753 unaffected siblings, and 1542 healthy comparison participants. The Structured Interview for Schizotypy-Revised (SIS-R) was administered to analyse scores of total, positive, and negative schizotypy in siblings and healthy comparison participants. The PRS-SCZ was trained using the Psychiatric Genomics Consortiums results and the ES-SCZ was calculated guided by the approach validated in a previous report in the current data set. Regression models were applied to test the independent and joint effects of PRS-SCZ and ES-SCZ (adjusted for age, sex, and ancestry using 10 principal components).

RESULTS:

Both genetic and environmental vulnerability were associated with case-control status. Furthermore, there was evidence for additive interaction between binary modes of PRS-SCZ and ES-SCZ (above 75% of the control distribution) increasing the odds for schizophrenia spectrum diagnosis (relative excess risk due to interaction = 6.79, [95% confidential interval (CI) 3.32, 10.26], p < 0.001). Sensitivity analyses using continuous PRS-SCZ and ES-SCZ confirmed gene-environment interaction (relative excess risk due to interaction = 1.80 [95% CI 1.01, 3.32], p = 0.004). In siblings and healthy comparison participants, PRS-SCZ and ES-SCZ were associated with all SIS-R dimensions and evidence was found for an interaction between PRS-SCZ and ES-SCZ on the total (B = 0.006 [95% CI 0.003, 0.009], p < 0.001), positive (B = 0.006 [95% CI, 0.002, 0.009], p = 0.002), and negative (B = 0.006, [95% CI 0.004, 0.009], p < 0.001) schizotypy dimensions.

CONCLUSIONS:

The interplay between exposome load and schizophrenia genetic liability contributing to psychosis across the spectrum of expression provide further empirical support to the notion of aetiological continuity underlying an extended psychosis phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Herança Multifatorial Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Herança Multifatorial Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article